Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Chemours' short interest surged, yet it beat earnings expectations, maintaining a "Moderate Buy" rating.
The Chemours Company (NYSE:CC) saw its short interest rise by 19.5% in March, with 10.53 million shares now shorted.
Despite this, Chemours beat earnings expectations with a $0.11 EPS, slightly higher than the $0.10 consensus.
The stock has a "Moderate Buy" rating with a $22.56 target price.
Barclays lowered its price target to $16, while Sei Investments increased its stake by 154,709 shares.
4 Articles
El interés en corto de Chemours aumentó, pero superó las expectativas de ganancias, manteniendo una calificación de "Comprar Moderado".